An immunoinformatics approach to epitope-based vaccine design against PspA in Streptococcus pneumoniae.

The in silico analysis has proven the vaccine as an alternative medication to combat against S. pneumoniae. The designated vaccine can be further tested in the wet lab, and a novel vaccine can be developed.